INDOMETHACIN ER is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Apotheca, Inc.. The primary component is Indomethacin.
| Product ID | 12634-838_543aa8e5-219e-41d8-8ffa-9ae1446d3391 |
| NDC | 12634-838 |
| Product Type | Human Prescription Drug |
| Proprietary Name | INDOMETHACIN ER |
| Generic Name | Indomethacin |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 2006-05-02 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA074464 |
| Labeler Name | Apotheca, Inc. |
| Substance Name | INDOMETHACIN |
| Active Ingredient Strength | 75 mg/1 |
| Pharm Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |
| NDC Exclude Flag | E |
| Listing Certified Through | 2018-12-31 |
| Marketing Start Date | 2006-05-02 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA074464 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2006-05-02 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA074464 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2006-05-02 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA074464 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2006-05-02 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA074464 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2006-05-02 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA074464 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2006-05-02 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA074464 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2006-05-02 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA074464 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2006-05-02 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA074464 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2006-05-02 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA074464 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2006-05-02 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA074464 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2006-05-02 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA074464 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2006-05-02 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA074464 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2006-05-02 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA074464 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2006-05-02 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA074464 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2006-05-02 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA074464 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2006-05-02 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA074464 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2006-05-02 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA074464 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2006-05-02 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA074464 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2006-05-02 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | ANDA |
| Application Number | ANDA074464 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2006-05-02 |
| Inactivation Date | 2020-01-31 |
| Ingredient | Strength |
|---|---|
| INDOMETHACIN | 75 mg/1 |
| SPL SET ID: | 6569dfd1-0164-4241-b508-ccd540d1e858 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| PHarm Class EPC | |
| NUI Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 12634-160 | INDOMETHACIN ER | INDOMETHACIN |
| 12634-838 | INDOMETHACIN ER | INDOMETHACIN |
| 42211-101 | INDOCIN | indomethacin |
| 42211-102 | INDOCIN | Indomethacin |
| 0185-0720 | Indomethacin | Indomethacin |
| 0378-0143 | Indomethacin | indomethacin |
| 0378-0147 | Indomethacin | indomethacin |
| 0409-1113 | Indomethacin | Indomethacin |
| 0440-1652 | Indomethacin | indomethacin |
| 0713-0176 | INDOMETHACIN | INDOMETHACIN |
| 10544-083 | Indomethacin | Indomethacin |
| 10544-216 | Indomethacin | indomethacin |
| 10544-234 | Indomethacin | indomethacin |
| 10544-919 | Indomethacin | Indomethacin |
| 10544-935 | Indomethacin | Indomethacin |
| 10702-016 | INDOMETHACIN | Indomethacin |
| 21695-522 | Indomethacin | Indomethacin |
| 21695-523 | Indomethacin | Indomethacin |
| 23155-010 | Indomethacin | Indomethacin |
| 23155-011 | Indomethacin | Indomethacin |
| 31722-542 | Indomethacin | Indomethacin |
| 31722-543 | Indomethacin | Indomethacin |
| 31722-565 | Indomethacin | Indomethacin |
| 33261-133 | Indomethacin | indomethacin |
| 35356-697 | Indomethacin | Indomethacin |
| 42254-081 | Indomethacin | Indomethacin |
| 42254-237 | INDOMETHACIN | indomethacin |
| 42708-030 | indomethacin | indomethacin |
| 43063-368 | Indomethacin | Indomethacin |
| 42211-201 | Tivorbex | indomethacin |
| 42211-202 | Tivorbex | indomethacin |